Truvestments Capital »

Sab Biotherapeutics shares owned by Truvestments Capital

Quarter-by-quarter ownership of Sab Biotherapeutics (SABS) shares owned by Truvestments Capital from 13F filings

Historical chart of Truvestments Capital investment in Sab Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sab Biotherapeutics held by Truvestments Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sab Biotherapeutics by Truvestments Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.3k 1.1k 3.90

More positions owned by Truvestments Capital

NVIDIA Corporation (NVDA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Corning Incorporated (GLW)
Broadcom (AVGO)
Apple (AAPL)
Caterpillar (CAT)
Applied Materials (AMAT)
Celestica (CLS)
Dell Technologies CL C (DELL)
Qualcomm (QCOM)
Marvell Technology (MRVL)
Ryder System (R)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Johnson & Johnson (JNJ)

View all positions for Truvestments Capital

Top funds holding Sab Biotherapeutics

Caligan Partners
Vivo Capital
Perceptive Advisors
Adage Capital Partners GP
RA Capital Management
Balyasny Asset Management
BlackRock
Vanguard Capital Management
Commodore Capital
Millennium Management
Spruce Street Capital
Sessa Capital IM
Affinity Asset Advisors
Boothbay Fund Management
Geode Capital Management

View all funds holding Sab Biotherapeutics